Product image of Latanoprost Noridem (Latanoprost) supplied by GNH India

Latanoprost Noridem

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Noridem (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Noridem, is a prostaglandin F2α analog presented as an ophthalmic solution for ocular use. It enhances uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension.

GNH India supplies Latanoprost Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing EU‑sourced quality for eye‑care professionals. All batches meet European Pharmacopoeia standards and are shipped under controlled conditions to preserve sterility, through validated logistics networks.

Manufacturer / TM Owner

Noridem Enterprises Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latanoprost is a prostaglandin analog used to lower intra‑ocular pressure in glaucoma‑related conditions.

  • Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression.
  • Ocular hypertension: lowers pressure to prevent conversion to glaucoma.
  • Secondary open‑angle glaucoma: helps control pressure when other causes are present.

How It Works

  • Latanoprost binds to prostaglandin F (FP) receptors on the ciliary muscle, activating a cascade that remodels extracellular matrix and increases uveoscleral outflow of aqueous humor. This enhanced drainage lowers intra‑ocular pressure, addressing the primary pathogenic factor in open‑angle glaucoma and ocular hypertension.

Side Effects

Latanoprost may cause ocular and systemic reactions.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Eyelash changes: increased length, thickness, or darkness.
  • Iris pigmentation: gradual darkening of the iris.
  • Eye irritation: foreign‑body sensation or mild discomfort.
  • Blurred vision: transient visual disturbance after instillation.
  • Periorbital skin darkening: mild hyperpigmentation around the eye.

Serious or Rare Side Effects

  • Severe allergic reaction: swelling, itching, or rash requiring medical attention.
  • Paradoxical IOP increase: unexpected rise in intra‑ocular pressure.
  • Corneal edema: swelling of the cornea that can affect vision.
  • Uveitis: inflammation of the uveal tract.
  • Macular edema: fluid accumulation in the central retina, potentially impairing central vision.

Precautions & Warnings

Before using Latanoprost, consider the following safety measures.

  • Monitor IOP: measure intra‑ocular pressure before and after therapy initiation.
  • Avoid contact lens use: discontinue lenses for at least six weeks after starting treatment.
  • Assess for ocular infections: do not use if an active eye infection is present.
  • Pregnancy and lactation: safety not established; use only if benefit outweighs potential risk.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid)

  • Concurrent prostaglandin analog eye drops: may increase risk of ocular side effects.
  • Systemic carbonic anhydrase inhibitors: additive IOP‑lowering effect may cause hypotony.

Moderate Interactions (Monitor Closely)

  • Topical corticosteroids: may reduce latanoprost efficacy.
  • Non‑steroidal anti‑inflammatory eye drops: may increase ocular irritation.
  • Beta‑blocker eye drops: additive IOP reduction; monitor pressure closely.

Frequently Asked Questions

Latanoprost Noridem is an ophthalmic solution used to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension. By reducing pressure, it helps prevent optic nerve damage and visual field loss associated with these eye conditions.

Latanoprost is a prostaglandin F2α analog that binds to FP receptors in the eye, stimulating remodeling of the extracellular matrix in the ciliary body. This process increases uveoscleral outflow of aqueous humor, thereby decreasing intra‑ocular pressure.

The dosing regimen for Latanoprost Noridem is determined by the prescribing eye‑care professional. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

Safety of latanoprost in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often have a more favorable dosing convenience and comparable pressure‑reduction results.

Store the ophthalmic solution at room temperature, below 25 °C, in the original packaging. Protect it from light and moisture, and keep the bottle tightly closed when not in use to maintain sterility.

Latanoprost Noridem is applied as a single drop into the conjunctival sac of the affected eye(s) once daily, preferably in the evening. The patient should avoid touching the tip of the bottle to the eye or any surface to prevent contamination.

Serious risks, though rare, include severe allergic reactions, paradoxical increase in intra‑ocular pressure, corneal edema, uveitis, and macular edema. Patients should seek immediate medical attention if they experience sudden vision changes, eye pain, or signs of infection.

Latanoprost should not be used by individuals with active ocular infections, hypersensitivity to latanoprost or any component of the formulation, or by those who have had a severe reaction to other prostaglandin analog eye drops. Consultation with an eye‑care professional is essential before starting therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT